Innovent Biologics, Inc. (HKG:1801)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
85.20
-1.70 (-1.96%)
Oct 22, 2025, 2:45 PM HKT

Innovent Biologics Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Net Income
1,132-94.63-1,028-2,179-2,729-998.42
Upgrade
Depreciation & Amortization
399.48332.16310.22276.79202.1785.63
Upgrade
Other Amortization
87.6187.6174.8942.642.58-
Upgrade
Loss (Gain) From Sale of Assets
0.6122.990.95-0.060.711.2
Upgrade
Asset Writedown & Restructuring Costs
355.72632.57115.36---
Upgrade
Loss (Gain) From Sale of Investments
-189.14-179.03-30.81-5.1-125.02-30.98
Upgrade
Loss (Gain) on Equity Investments
64.5741.01----
Upgrade
Stock-Based Compensation
601.18556.52574.2469.49501.57402.5
Upgrade
Other Operating Activities
-321.9-515.93-272.47-833.19213.88566.44
Upgrade
Change in Accounts Receivable
-353.41-178.52-430.62393.14-493.03-225.34
Upgrade
Change in Inventory
-371.75180.63358.95-105.39-643.28-311.43
Upgrade
Change in Accounts Payable
211.67-14.8746.93130.5774.4336.35
Upgrade
Change in Unearned Revenue
-1.35-31.19-138.63205.04105.4355.12
Upgrade
Change in Other Net Operating Assets
200.82447.71566.77-313.45864.46111.24
Upgrade
Operating Cash Flow
1,8161,287147.81-1,919-2,025-307.69
Upgrade
Operating Cash Flow Growth
227.24%770.73%----
Upgrade
Capital Expenditures
-368.73-965.67-1,119-896.9-1,066-489.02
Upgrade
Sale of Property, Plant & Equipment
-0.270.050.190.10.04
Upgrade
Sale (Purchase) of Intangibles
-803.36-676.42-262.35-468.6-781.88-32.63
Upgrade
Sale (Purchase) of Real Estate
--16.23---
Upgrade
Investment in Securities
331.25-981.19-204.43-384.74-254.58-4,490
Upgrade
Other Investing Activities
773.911,458571.22314.87-596.15-173.02
Upgrade
Investing Cash Flow
-66.93-1,165-998.66-1,435-2,698-5,185
Upgrade
Long-Term Debt Issued
-515.571,3361,0801,463372.18
Upgrade
Long-Term Debt Repaid
--1,246-948.85-392.74-278.72-33.79
Upgrade
Net Debt Issued (Repaid)
147.67-730.44386.7687.431,184338.39
Upgrade
Issuance of Common Stock
79.4884.312,2552,1313,9514,662
Upgrade
Other Financing Activities
75.4539.5-54.5673.59-131.52-88.63
Upgrade
Financing Cash Flow
302.6-606.632,5872,8925,0034,912
Upgrade
Foreign Exchange Rate Adjustments
4.2612.68-6.88118.66-197.14-569.47
Upgrade
Net Cash Flow
2,056-472.341,730-343.2483.23-1,150
Upgrade
Free Cash Flow
1,448321.36-971.58-2,816-3,090-796.71
Upgrade
Free Cash Flow Margin
12.67%3.41%-15.65%-61.80%-72.38%-20.73%
Upgrade
Free Cash Flow Per Share
0.870.20-0.62-1.89-2.12-0.59
Upgrade
Cash Interest Paid
122.14122.43127.61104.8878.8345.83
Upgrade
Cash Income Tax Paid
1.330.16-114.4266.126.44139.71
Upgrade
Levered Free Cash Flow
89.38-113.22-907.54-2,475-2,612-806.08
Upgrade
Unlevered Free Cash Flow
146.18-70.94-845.9-2,411-2,573-763.36
Upgrade
Change in Working Capital
-314.03403.76403.39309.91-91.98-334.06
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.